Literature DB >> 2720862

Atracurium, pharmacokinetics and metabolites.

F Donati1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2720862     DOI： 10.1007/BF03010761

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN： 0832-610X            Impact factor:   5.063


× No keyword cloud information.
  21 in total

1.  Dual action of suxamethonium chloride.

Authors:  H J BRENNAN
Journal:  Br J Anaesth       Date:  1956-04       Impact factor: 9.166

2.  The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug.

Authors:  J J Savarese; H H Ali; S J Basta; P B Embree; R P Scott; N Sunder; J N Weakly; W B Wastila; H A el-Sayad
Journal:  Anesthesiology       Date:  1988-05       Impact factor: 7.892

3.  Mivacurium chloride (BW B1090U)-induced neuromuscular blockade during nitrous oxide-isoflurane and nitrous oxide-narcotic anesthesia in adult surgical patients.

Authors:  S Weber; B W Brandom; D M Powers; J B Sarner; S K Woelfel; D R Cook; V J Foster; B F McNulty; J N Weakly
Journal:  Anesth Analg       Date:  1988-06       Impact factor: 5.108

4.  Pharmacokinetics of atracurium and its metabolites in patients with normal renal function, and in patients in renal failure.

Authors:  S Ward; N Boheimer; B C Weatherley; R J Simmonds; T A Dopson
Journal:  Br J Anaesth       Date:  1987-06       Impact factor: 9.166

5.  In vitro degradation of atracurium in human plasma.

Authors:  R A Merrett; C W Thompson; F W Webb
Journal:  Br J Anaesth       Date:  1983-01       Impact factor: 9.166

6.  Comparative toxicity of atracurium and metocurine in isolated rat hepatocytes.

Authors:  V Nigrovic; J E Klaunig; S L Smith; N E Schultz; A Wajskol
Journal:  Anesth Analg       Date:  1986-11       Impact factor: 5.108

7.  The role of metabolism and protein binding in thiopental anesthesia.

Authors:  P G Burch; D R Stanski
Journal:  Anesthesiology       Date:  1983-02       Impact factor: 7.892

8.  The pharmacokinetics of atracurium isomers in vitro and in humans.

Authors:  D Tsui; G G Graham; T A Torda
Journal:  Anesthesiology       Date:  1987-11       Impact factor: 7.892

9.  In vitro degradation of atracurium in human plasma.

Authors:  R L Stiller; D R Cook; S Chakravorti
Journal:  Br J Anaesth       Date:  1985-11       Impact factor: 9.166

10.  Disposition of infusions of atracurium and its metabolite, laudanosine, in patients in renal and respiratory failure in an ITU.

Authors:  C J Parker; J E Jones; J M Hunter
Journal:  Br J Anaesth       Date:  1988-11       Impact factor: 9.166
View more
  1 in total

Review 1.  Clinical pharmacokinetics of neuromuscular blocking drugs.

Authors:  S Agoston; R H Vandenbrom; J M Wierda
Journal:  Clin Pharmacokinet       Date:  1992-02       Impact factor: 6.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.